ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Veblocema 120 mg, solution injectable en stylo prérempli - 2
67888002 iQone Healthcare Switzerland SA
Veblocema 120 mg, solution injectable en stylo prérempli29.06.2021
  29.06.2021
Infliximab (L04AB02) 
WHO-DDD28.06.2026
07.15.2
07.15. 
A  
No 
IPCI
PR  
k.A.PR
  
7680678880024Biotechnologika
  
Composition
infliximabum 120 mg, acidum aceticum, natrii acetas trihydricus, sorbitolum 45 mg, polysorbatum 80, aqua ad iniectabile, q.s. ad solutionem pro 1 ml corresp. natrium 0.16 mg.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Infliximab120 mg/ml
BAG: Active AgentDose
Infliximab120 mg
 
Inactive agentsDose
Acetic Acid 
Sodium Acetate Trihydrate 
Polysorbatum 80 
Sorbitol45 mg/ml
 
Source
Data was imported : 04.04.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home